Taylor R, Barnes A, Hollingsworth K, Irvine K, Solovyova A, Clark L
    
    
    Clin Sci (Lond). 2023; 137(16):1333-1346.
  
  
    PMID: 37593846
    
          PMC: 10472166.
    
          DOI: 10.1042/CS20230586.
      
 
                                  
  
    Taylor R
    
    
    J Intern Med. 2020; 289(6):754-770.
  
  
    PMID: 33289165
    
          PMC: 8247294.
    
          DOI: 10.1111/joim.13214.
      
 
                                  
  
    Bevan G, De Poli C, Keng M, Raine R
    
    
    BMJ Open. 2020; 10(3):e033483.
  
  
    PMID: 32132137
    
          PMC: 7059487.
    
          DOI: 10.1136/bmjopen-2019-033483.
      
 
                                  
  
    Knowler W, Crandall J
    
    
    Curr Diab Rep. 2019; 19(12):154.
  
  
    PMID: 31792721
    
    
          DOI: 10.1007/s11892-019-1268-5.
      
 
                                  
  
    Sheng Z, Cao J, Pang Y, Xu H, Chen J, Yuan J
    
    
    Front Endocrinol (Lausanne). 2019; 10:455.
  
  
    PMID: 31354627
    
          PMC: 6639788.
    
          DOI: 10.3389/fendo.2019.00455.
      
 
                              
              
                              
                                      
  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
  
    Richter B, Hemmingsen B, Metzendorf M, Takwoingi Y
    
    
    Cochrane Database Syst Rev. 2018; 10:CD012661.
  
  
    PMID: 30371961
    
          PMC: 6516891.
    
          DOI: 10.1002/14651858.CD012661.pub2.
      
 
                                          
                                                          
  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
  
    Hemmingsen B, Gimenez-Perez G, Mauricio D, Roque I Figuls M, Metzendorf M, Richter B
    
    
    Cochrane Database Syst Rev. 2017; 12:CD003054.
  
  
    PMID: 29205264
    
          PMC: 6486271.
    
          DOI: 10.1002/14651858.CD003054.pub4.
      
 
                                          
                                                          
  Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
  
    Aroda V, Knowler W, Crandall J, Perreault L, Edelstein S, Jeffries S
    
    
    Diabetologia. 2017; 60(9):1601-1611.
  
  
    PMID: 28770322
    
          PMC: 5709233.
    
          DOI: 10.1007/s00125-017-4361-9.
      
 
                                          
                                                          
  The prevention of type 2 diabetes.
  
    Crandall J, Knowler W, Kahn S, Marrero D, Florez J, Bray G
    
    
    Nat Clin Pract Endocrinol Metab. 2008; 4(7):382-93.
  
  
    PMID: 18493227
    
          PMC: 2573045.
    
          DOI: 10.1038/ncpendmet0843.
      
 
                                          
                                                          
  Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.
  
    Gillies C, Lambert P, Abrams K, Sutton A, Cooper N, Hsu R
    
    
    BMJ. 2008; 336(7654):1180-5.
  
  
    PMID: 18426840
    
          PMC: 2394709.
    
          DOI: 10.1136/bmj.39545.585289.25.
      
 
                                          
                                                          
  High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.
  
    Piche M, Lemieux S, Perusse L, Weisnagel S
    
    
    Diabetologia. 2005; 48(4):732-40.
  
  
    PMID: 15765221
    
    
          DOI: 10.1007/s00125-005-1701-y.
      
 
                                          
                                                          
  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
  
    
    
    
    Diabetes Care. 2000; 23(11):1619-29.
  
  
    PMID: 11092283
    
          PMC: 1360735.
    
          DOI: 10.2337/diacare.23.11.1619.
      
 
                                          
                                                          
  Background and recruitment data for the U.S. Diabetes Prevention Program.
  
    Fujimoto W
    
    
    Diabetes Care. 2000; 23 Suppl 2:B11-3.
  
  
    PMID: 10860185
    
          PMC: 2505054.
    
      
 
                                          
                                                          
  Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria.
  
    Olatunbosun S, Ojo P, Fineberg N, Bella A
    
    
    J Natl Med Assoc. 1998; 90(5):293-301.
  
  
    PMID: 9617070
    
          PMC: 2608340.
    
      
 
                                          
                                                          
  Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.
  
    Edelstein S, Knowler W, Bain R, Andres R, Barrett-Connor E, Dowse G
    
    
    Diabetes. 1997; 46(4):701-10.
  
  
    PMID: 9075814
    
          PMC: 2517225.
    
          DOI: 10.2337/diab.46.4.701.
      
 
                                          
                                                          
  Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.
  
    Pfeffer F, Nauck M, Benz S, Gwodzinski A, Zink R, Busing M
    
    
    Diabetologia. 1996; 39(4):462-8.
  
  
    PMID: 8777996
    
    
          DOI: 10.1007/BF00400678.
      
 
                                          
                                                          
  Impaired glucose tolerance.
  
    Davies M, Gray I
    
    
    BMJ. 1996; 312(7026):264-5.
  
  
    PMID: 8611769
    
          PMC: 2349870.
    
          DOI: 10.1136/bmj.312.7026.264.
      
 
                                          
                                                          
  The value of screening for diabetes in patients with skin sepsis.
  
    Baynes C, Caplan S, Hames P, Swift R, Poole S, Wadsworth J
    
    
    J R Soc Med. 1993; 86(3):148-51.
  
  
    PMID: 8459378
    
          PMC: 1293904.
    
          DOI: 10.1177/014107689308600311.
      
 
                                          
                                                          
  Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up.
  
    Lehtinen J, Niskanen L, Hyvonen K, Siitonen O, Uusitupa M
    
    
    Diabetologia. 1993; 36(1):68-72.
  
  
    PMID: 8436256
    
    
          DOI: 10.1007/BF00399096.
      
 
                                          
                                                          
  Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.
  
    Mykkanen L, Kuusisto J, Pyorala K, Laakso M
    
    
    Diabetologia. 1993; 36(6):553-9.
  
  
    PMID: 8335178
    
    
          DOI: 10.1007/BF02743273.